MicroRNA-455-5p (miR-455-5p) seems to have an anti-inflammatory role in the immune system since its expression is induced by IL-10 cytokine. Multiple sclerosis (MS) is a chronic demyelinating neurodegenerative disease of the central nervous system that is caused by an autoimmune inflammatory attack against the myelin insulation of neurons. The expression level of miR-455-5p and its role in MS pathogenesis has yet to be elucidated. We found that miR-455-5p expression was highly correlated with disease severity in MS patients. miR-455-5p expression inversely correlates with its inflammatory-predicted targets (MyD88 and REL) in relapse- and remitting-phase patients. Luciferase assays confirm that MyD88 and REL are direct targets of miR-455-5p. This study represents the first report of the miR-455-5p acts as an anti-inflammatory role in MS, at least partially through targeting MyD88 and REL. This study may provide important information for the use of miR-455-5p as a novel strategy to improve the severity of disease and control inflammation and attack in MS patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00251-018-1087-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics.
Am J Hematol
January 2025
Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Article Synopsis
- High-grade B-cell lymphoma not otherwise specified (HGBCL, NOS) shares similarities with diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL), which complicates its diagnosis and treatment.
- A study on a cohort of 55 patients revealed that about 60% of HGBCL, NOS cases don't express the BL gene signature and instead display characteristics aligned with DLBCL, while showing significant genetic diversity and changes in critical regulatory genes.
- Pediatric HGBCL, NOS cases exhibited gene expressions typical of GCB-DLBCL and also showed key mutations seen in pediatric BL; the research highlighted PIM1 mutations in adults as a potential target for new therapies.
SOCS6, an inhibitory factor in Japanese eel inhibits the type I IFN pathway and the MyD88-mediated NF-kB pathway.
Fish Shellfish Immunol
November 2024
Key Laboratory of Healthy Mariculture for the East China Sea, Ministry of Agriculture and Rural Affairs, Fisheries College, Jimei University, Xiamen, Fujian Province, 361021, China; Engineering Research Center of the Modern Technology for Eel Industry, Ministry of Education, China; Fisheries College, Jimei University, Xiamen, Fujian Province, 361021, China. Electronic address:
SOCS family genes are a class of repressors in various signaling pathways of mammals involved in regulating immunity, growth, and development, but the information remains limited in teleost. The full-length cDNA sequence of the Japanese eel SOCS6 gene, named AjSOCS6, was first cloned and showed to encode 529 amino acids with a conserved SH2 structural domain and a typical structure of a C-terminal SOCS box. AjSOCS6 is evolutionarily close to that of rainbow trout and zebrafish.
View Article and Find Full Text PDFEmodin treatment of papillary thyroid cancer cell lines inhibits proliferation and enhances apoptosis via downregulation of NF‑κB and its upstream TLR4 signaling.
Oncol Lett
December 2023
National Key-Laboratory of Intelligent Tracing and Forecasting for Infectious Disease, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, P.R. China.
Article Synopsis
- Thyroid cancer is a common endocrine cancer and this study investigates the potential of emodin in treating papillary thyroid carcinoma (PTC) by focusing on its effects on NF-κB components and TLR4 signaling.
- Emodin treatment reduced the expression levels of key NF-κB components and inhibited both MYD88-dependent and independent pathways, leading to decreased cell proliferation and increased apoptosis.
- The results indicate that emodin could effectively diminish the invasive and migratory capabilities of PTC cells, suggesting it as a promising therapeutic option.
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Blood Adv
September 2023
Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
Article Synopsis
- Follicular lymphoma (FL) varies greatly among patients, with some needing immediate treatment due to aggressive disease while others can monitor their condition without intervention.
- A study analyzed the genetic alterations in FL across 370 patients, discovering that higher mutation burdens were present in relapsed or transformed FL but not linked to better outcomes in newly diagnosed cases.
- A set of 7 specific gene mutations (MAP signature) was identified that indicates a shorter progression-free survival in newly diagnosed FL, which could help better predict patient outcomes beyond existing prognostic tools.
SUMO and PIAS repress NF-κB activation in a basal chordate.
Fish Shellfish Immunol
June 2023
Guangdong Key Laboratory of Pharmaceutical Functional Genes, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangdong, China; Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China. Electronic address:
Small ubiquitin-like modifier (SUMO) regulates various biological processes, including the MyD88/TICAMs-IRAKs-TRAF6-NF-κB pathway, one of the core immune pathways. However, its functions are inconsistent between invertebrates and vertebrates and have rarely been investigated in lower chordates, including amphioxus and fishes. Here, we investigated the SUMOylation gene system in the amphioxus, a living basal chordate.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!